Article · 16 Feb 2025
Research articlePublished 3 May 2019
A validated HPTLC method for determination of simultaneous estimation Rosuvastatin Calcium and Ezetimibe in pharmaceutical solid dosage form
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This paper Described validated high performance liquid chromatographic (HPTLC) method for estimation of Rosuvastatin Calcium (ROS) and Ezetimibe (EZE) in tablet dosage form. The method involved separation of components by TLC on a precoated silica gel 60 F254 using a mixture of n-butanol: methanol (3:1) as a mobile phase. Detection of spots was carried out at 274 nm and 230 nm for Rosuvastatin Calcium and Ezetimibe combinations, respectively. The mean retardation factor for Rosuvastatin Calcium and Ezetimibe were found to be 0.90 ±0.01, 0.82±0.05, respectively. The linearity and range was 0.1 to 0.5 μg/spot for two drugs. The method was validated for precision, accuracy and reproducibility
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Archives of Applied Science Research.
Article · 30 Aug 2024
Exploring the Depths: Advances in Marine Sciences
Article · 30 Aug 2024
Unveiling the Microbial World: Advances in Applied Microbiology
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives of Applied Science Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “MC. Sharma”
- BylineArticles whose byline prints “Smita Sharmaa”
- BylineArticles whose byline prints “DV. Kohlib”
- BylineArticles whose byline prints “AD. Sharmac”